Clinical Trial Update: mtDNA as Novel Biomarker for Intra-amniotic Infection

View source ↗

Summary

This clinical trial update investigates mitochondrial DNA as a novel biomarker for intra-amniotic infection in pregnancies affected by preterm premature rupture…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intra-amniotic Infection
• Preterm Premature Rupture of Membranes

Snippet

Sponsor: Medical University of Vienna | Conditions: Preterm Premature Rupture of Membrane | Status: UNKNOWN